Patients with antiphospholipid antibodies (aPL) are at increased risk for arterial or venous thrombosis. There is, however, significant heterogeneity among patients according to clinical and ...

Hurlen M et al. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002 Sep 26; 347:969-74. Becker RC. Antithrombotic therapy after myocardial infarction.

There is controversy regarding the appropriate strategy (anticoagulation vs aspirin) for stroke prevention in low-risk patients (CHA2DS2-VASc score of 0–1). Novel anticoagulants include ...